Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 3380
115th Congress(2017-2018)
A bill to direct the Office of National Drug Control Policy to track and review federally funded drug demand reduction activities.
Introduced
Introduced
Introduced in Senate on Aug 23, 2018
Overview
Text
Introduced in Senate 
Aug 23, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Aug 23, 2018)
Aug 23, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 3380 (Introduced-in-Senate)


115th CONGRESS
2d Session
S. 3380


To direct the Office of National Drug Control Policy to track and review federally funded drug demand reduction activities.

IN THE SENATE OF THE UNITED STATES

August 23, 2018

Mr. Donnelly introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To direct the Office of National Drug Control Policy to track and review federally funded drug demand reduction activities.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Federal drug demand reduction activities.

(a) Definitions.—In this section—

(1) the term “demand reduction activity” means any activity, other than an enforcement activity, that is intended to reduce the use of drugs; and

(2) the term “Director” means the Director of National Drug Control Policy.

(b) Tracking system.—The Director—

(1) shall establish a system to track federally funded demand reduction activities; and

(2) in establishing the system under paragraph (1), shall consult with, and leverage any tracking of federally funded demand reduction activities by—

(A) the Secretary of Homeland Security;

(B) the Attorney General; and

(C) the head of any other Federal agency that operates a program or awards grants relating to demand reduction activities.

(c) Public list.—The Director shall publish online a list of all Federal programs and grants relating to demand reduction activities.

(d) Annual strategy.—In formulating the annual National Drug Control Strategy, the Director shall review all federally funded demand reduction activities, including an evaluation of—

(1) the effectiveness of those activities;

(2) the contribution of those activities to demand reduction activities funded by States or units of local government; and

(3) whether any duplication or inefficiency in federally funded demand reduction activities needs to be addressed.